Bo Lu, MD, PhD, is a radiation oncologist who treats lung cancers and other cancers of the thorax. He joined MU Health Care’s Ellis Fischel Cancer Center to offer patients in mid-Missouri personalized cancer treatment that maximizes their chance for cure and minimizes treatment-related side effects. To accomplish this, Dr. Lu and his clinical team employ state-of-art radiotherapy equipment to ensure every radiation treatment is delivered precisely at the targeted cancer, thus sparing adjacent healthy tissues from radiation injury. His research team conducts National Cancer Institute-sponsored investigations that develop blood tests and drugs for early diagnosis and treatment of serious side effects from cancer therapy.   

When Dr. Lu meets new patients, he likes to share with them his knowledge about their cancer and various treatment options, including radiotherapy. He helps patients select a treatment that fits them individually and stays with them throughout the journey of their treatment.   

In his free time, Dr. Lu enjoys the beautiful landscape of mid-Missouri, taking frequent jogs and biking along the MKT trails with his family and their Labrador retriever.

Education & Training

Medical School

Shanghai Medical University

Graduate Institution

Baylor College of Medicine


Transitional Year

  • UPMC-Presbyterian Hospital


Radiation Oncology

  • LAC-USC Medical Center


American Board of Radiology/Radiation Oncology


MU Health Care participates with most major managed care organizations. To find out whether MU Health Care is a participating provider in your insurance plan or network, or for information on co-payments and deductibles, please contact your insurance carrier directly.

Academic Information

Professor of Radiation Oncology
Chair of Radiation Oncology
NextGen Precision Health Investigator

Research Profile

Dr. Lu’s laboratory conducts National Cancer Institute-sponsored investigations that aim to understand how the immune system responds to various cancer treatments. They are making progress on developing blood tests and drugs to diagnose and treat serious side effects from combined radiotherapy and immunotherapy.